Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank:DB05077_nanopub.RAJc6cCgDrthj7o6L5DAvhUlh0o4m-9oVF1mWemcE2evE#assertion>. }
Showing items 1 to 12 of
12
with 100 items per page.
- drugbank:DB05077 type drugbank_vocabulary:Drug assertion.
- drugbank:DB05077 label "SLV319 [drugbank:DB05077]" assertion.
- drugbank:DB05077 seeAlso DB05077 assertion.
- drugbank:DB05077 description "SLV319 belongs to a novel class of agents called CB1 antagonists, which work by blocking the cannabinoid type 1 (CB1) receptor. It is developed for the treatment of obesity and other metabolic disorders." assertion.
- drugbank:DB05077 identifier "drugbank:DB05077" assertion.
- drugbank:DB05077 title "SLV319" assertion.
- drugbank:DB05077 drugbank_vocabulary:x-cas cas: assertion.
- drugbank:DB05077 drugbank_vocabulary:drugbank-id "DB05077" assertion.
- drugbank:DB05077 bio2rdf_vocabulary:x-identifiers.org DB05077 assertion.
- drugbank:DB05077 bio2rdf_vocabulary:uri "http://bio2rdf.org/drugbank:DB05077" assertion.
- drugbank:DB05077 bio2rdf_vocabulary:namespace "drugbank" assertion.
- drugbank:DB05077 bio2rdf_vocabulary:identifier "DB05077" assertion.